Gral Medical Diagnostic Center

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Prostate cancer2 trials
• Lung cancer1 trial

Phase

• Phase 32 trials
• Phase 2/31 trial

Status

• Active, not recruiting3 trials

Lead sponsor

• Eli Lilly and Company3 trials

Running trials

• Active, not recruiting

  A Study of Abemaciclib (LY2835219) With Abiraterone in Men With Prostate Cancer That Has Spread to Other Parts of the Body and is Expected to Respond to Hormonal Treatment (Metastatic Hormone-Sensitive Prostate Cancer)

  NCT05288166· Phase 3· Eli Lilly and Company· Source

• Active, not recruiting

  A Study of Selpercatinib (LY3527723) in Participants With Advanced or Metastatic RET Fusion-Positive Non-Small Cell Lung Cancer

  NCT04194944· Phase 3· Eli Lilly and Company· Source

• Active, not recruiting

  A Study of Abiraterone Acetate Plus Prednisone With or Without Abemaciclib (LY2835219) in Participants With Prostate Cancer

  NCT03706365· Phase 2/3· Eli Lilly and Company· Source